Latest:
Dr. Mirhadi on Patient Populations of Lung Cancer Optimal for Radiation
Amin J. Mirhadi, MD, discusses patient populations of lung cancer who should be treated with radiation therapy.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Amir Ahmed Toor, MD
Latest:
Computer Model Personalizes Donor Selection for Stem Cell Transplants
Investigators at Virginia Commonwealth University Massey Cancer Center are developing dynamical models that may allow clinicians to move beyond simple human leukocyte antigen matching to personalize immunosuppressive regimens and thus improve donor selection.
Amishi Desai, MD
Latest:
Dr. Desai on Immunotherapy in Patients With NSCLC and Low PD-L1 Expression
Amishi Desai, MD, assistant professor of medicine at Upstate University Hospital, discusses the use of immunotherapy in patients with non–small cell lung cancer (NSCLC) with PD-L1 expression less than 1%.
Amit Gupta, MD
Latest:
Dr. Gupta on the Role of Surgery in Bladder Cancer
Amit Gupta, MD, urologic oncologist, Department of Surgery, Cedars-Sinai Medical Center, discusses how the use of immunotherapy agents is altering the role of surgery in bladder cancer and the need for Bacillus Calmette-Guérin (BCG) alternatives.
Amol K. Narang, MD
Latest:
Dr. Narang Discusses Role of Radiation in Pancreatic Cancer
Amol K. Narang, MD, assistant professor of radiation oncology and molecular radiation sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, discusses the role of radiation therapy in the treatment of patients with pancreatic cancer.